HABA LABORATORIES, INC.JP:4925
Market cap
¥6.6B
P/E ratio
13.2x
| 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Depreciation & amortization | 584 | 616 | 538 | 617 | 617 | 630 | 669 | 708 | 560 | 519 | 159 |
| Cash from operations | -179 | 1,907 | 1,495 | 2,671 | 1,922 | 676 | 535 | 1,714 | 56 | -588 | 1,621 |
| Capital expenditures | -205 | -667 | -519 | -674 | -302 | -651 | -796 | -124 | -191 | -155 | -138 |
| Cash from investing | 687 | -363 | -962 | -924 | -471 | -920 | -925 | -216 | -214 | -442 | -147 |
| Payments for dividends | -79 | -79 | -79 | -118 | -118 | -157 | -151 | -151 | -151 | -151 | -151 |
| Repurchases of common stock | -0 | -0 | -0 | -0 | -1 | -1,157 | -0 | -0 | - | - | -0 |
| Proceeds from issuance of term debt, net | 750 | 450 | 800 | 750 | 400 | 1,750 | 1,210 | 400 | 400 | 800 | 400 |
| Repayments of term debt | -888 | -1,040 | -909 | -1,059 | -753 | -785 | -833 | -962 | -825 | -878 | -838 |
| Cash from financing | -319 | -1,470 | -538 | -427 | -572 | -449 | 825 | -1,513 | -676 | 171 | -689 |